Healthcare: Don’t Ignore European Stocks!
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 16 May 2018
⏱️ 27 minutes
🧾️ Download transcript
Summary
With a population of 741 million people, Europe’s a huge market for medicine, yet most U.S. investors avoid European drugmakers, including Sanofi. On today's episode, we explain how drugs win approval in Europe and why Sanofi ought to be on your radar.
Thanks to Molekule for supporting our channel. Get $75 off your first order at http://www.molekule.com code fool.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This episode of Industry Focus is brought to you by Molecule, the world's first molecular air purifier that reduces symptoms for allergy and asthma sufferers. |
| 0:08.0 | For $75 off your first order, Focus, the podcast that dives into a different sector of the stock market every day. |
| 0:24.0 | I'm your health care host, Christine Hargis, and I've got my usual sidekick Todd Campbell calling in. |
| 0:28.0 | It is May 16th, and we're smack in the middle of an international theme week here on industry focus. |
| 0:34.7 | Because we're a US-based podcast talking about the US stock market, we spend most of our time talking |
| 0:39.1 | about domestic companies. |
| 0:40.8 | But there's a whole world of stocks out there and no portfolio is truly diversified without |
| 0:45.3 | international exposure. |
| 0:47.0 | So this week we decided to change things up by focusing on international stories. |
| 0:51.4 | We'll start our show today with a high-level overview of how the drug |
| 0:54.2 | approval process works in Europe, noting the key ways in which is different from the |
| 0:58.3 | U.S. system and why it matters to your portfolio. Then we'll turn to Sanofi, France's largest drugmaker. But first |
| 1:05.6 | things first, what do our listeners need to know about drug approval in Europe? |
| 1:10.3 | Well it's a little bit different than it is in the US. I mean, there's some nuances that, you know, people ought to be aware of. I think, Christie, one of the things that might be helpful to the listeners just to put things into context and, you know, and add on to what you've already said, |
| 1:25.6 | is just how big the market is for medicine in Europe. |
| 1:30.0 | Because I think that we tend in the U.S investors to look at the US market and recognize that yeah |
| 1:36.6 | the US market in dollar terms is the biggest market on the planet, right? |
| 1:42.4 | But the European market is |
| 1:43.7 | still incredibly significant there are 741 million people who live in |
| 1:50.0 | Europe Christine yeah it's not insignificant. |
| 1:53.8 | And so it's something that even if you are looking at domestic companies, U.S. based companies, |
| 1:58.3 | they still are probably going to have some European exposure because if you can get a drug approved in the United States, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.